Purnasari, Santi
Unknown Affiliation

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

ANALISIS INTERAKSI OBAT ANTIDIABETIK ORAL PADA PASIEN RAWAT JALAN DI RUMAH SAKIT X DEPOK Purnasari, Santi; Jufri, Mahdi; Sari, Dini Permata
Jurnal Farmasi Indonesia Vol 4, No 1 (2008)
Publisher : Jurnal Farmasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfi.v4i1.3

Abstract

Oral antidiabetic medications has been used over 40 years to control blood glucosa level. Type 2 diabetes mellitus usually complicate with several chronic disease that cause diabetic therapy usually combined with other medications.  This increase the possibility of drug interaction. The present research was done to reveal the prescribing pattern and drug interaction problem in a hospital (Hospital X) at Depok. Data was collected from 307 prescriptions contain oral antidiabetic which were prescribe during January 2005-May 2006. Result showed that the most prescribe oral antidiabetic medication was glimepiride (45,89%). Drug interaction occurred in 41,69% prescriptions. Using statistical analysis Chi square it was revealed that there is significant correlation between the number of medication in one prescription with the number of drug interaction found.  ABSTRAK Obat antidiabetik oral telah digunakan selama 40 tahun terakhir untuk mengontrol kadar glukosa darah. Pada pasien diabetes melitus tipe 2 umumnya disertai dengan beberapa penyakit menahun, sehingga dalam terapi diabetes biasanya dikombinasikan dengan obat-obat lain. Hal ini meningkatkan terjadinya interaksi obat yang merugikan pasien. Penelitian ini bertujuan untuk mengetahui gambaran peresepan dan masalah interaksi obat di Rumah Sakit X Depok. Data diambil dari 307 resep obat antidiabetik oral selama bulan Januari 2005-Mei 2006. Obat golongan sulfonilurea yang paling banyak diresepkan adalah glimepirid (45,89%). Sebanyak 41,69% resep obat antidiabetik oral memiliki interaksi. Dengan menggunakan uji stastistik Kai Kuadrat diketahui adanya hubungan yang bermakna antara jumlah obat dalam satu resep yang mengandung obat antidiabetik oral dengan jumlah interaksi obat yang teridentifikasi.
EFEK HEPATOPROTEKTIF REBUSAN AKAR TAPAK LIMAN PADA TIKUS PUTIH YANG DIINDUKSI DENGAN KARBON TETRAKLORIDA Purnasari, Santi; Azizahwati, .; Ariani, Retno
Jurnal Farmasi Indonesia Vol 4, No 2 (2008)
Publisher : Jurnal Farmasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfi.v4i2.13

Abstract

Tapak liman (Elephantopus scaber Linn) has long been known as medicinal plant, and had been proved to have hepatoprotective activity.           This work was conducted to reveal the effective dose of tapak limanâ??s root decoct as hepatoprotector. Twenty four rats was distributed randomly into six groups, normal or negative control, positive control, three treated groups each receiving decoct of tapak limanâ??s root with doses of 0.1 g/200 g bw, 0.2 g/200 g bw, and 0.4 g/200 g bb, and the sixth group was treated with Hepasil® in dose of 0.19 g/200 g bw. All groups were treated for eight days, and at the end of day-8 all groups were treated with carbon tetrachloride in dose of 0.40 mg/g bw, and then sacrificed 48 hours later. The plasma ALT were measured using Reitman-Frankle colorimetry and lipid peroxide level in plasma and hepar were measured using Placer-Cushman-Johnson colorimetry. Results showed that the best dose showing highest hepatoprotective activity was 0,4 g/200 g bb. ABSTRAK Tapak liman (Elephantopus scaber Linn) telah lama dikenal sebagai tumbuhan obat, dan telah terbukti memiliki daya hepatoprotektif. Penelitian ini dilakukan dengan tujuan untuk mengetahui dosis efektif dari rebusan akar tapak liman sebagai hepatoprotektor. Dua puluh empat ekor tikus dibagi secara acak dalam enam kelompok. Kelompok I kontrol normal, dan kelompok II kontrol positif. Kelompok III, IV, V, kelompok perlakuan yaitu masing-masing mendapat rebusan akar tapak liman dengan dosis 0,1 g/200 g bb, 0,2 g/200 g bb, 0,4 g/200 g bb. Kelompok VI kontrol pembanding yang diberikan obat Hepasil® dengan dosis 0,19 g/200 g bb. Tiap kelompok mendapatkan perlakuan selama 8 hari, kemudian diberi karbon tetraklorida dengan dosis 0,40 mg/g bb dan 48 jam berikutnya dibedah. Pengamatan dilakukan melalui aktivitas ALT plasma dengan metode kolorimetri Reitman-Frankle dan kadar peroksida lipid plasma serta hati dengan metode kolorimetri Placer-Cushman-Johnson. Berdasarkan pengamatan aktivitas ALT plasma dan kadar peroksida lipid plasma serta hati diketahui bahwa rebusan akar tapak liman dengan dosis 0,4 g/200 g bb memiliki efek hepatoprotektif paling baik.
A Pemantauan Kadar Obat Dalam Darah Bedaquilin dan Linezolid Pada Pasien Tuberculosis Resistensi Obat : Literatur Review Yeni, Ai Yeni Herlinawati; Andrajati, Retnosari; Purnasari, Santi
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol. 17 No. 2 (2025): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfionline.v17i2.320

Abstract

Tuberculosis remains a leading cause of global mortality and morbidity. Current TB elimination programs have not yet met their targets. Drug resistance poses a significant challenge, necessitating effective alternative treatments for drug-resistant TB patients. Bedaquiline and Linezolid are primary drugs (Category A) used to combat drug-resistant TB. However, they come with side effects and toxicity, have narrow therapeutic window, and exhibit pharmacokinetic variability. Therefore, therapeutic drug monitoring (TDM) is recommended to achieve desired treatment outcomes and prevent or minimize potential side effects or toxicity. The objective of this study is to assess the urgency of TDM implementation to address these issues. This research is a literature review involving the synthesis of data from six studies that met inclusion and exclusion criteria. Data sources include Science Direct, PubMed, and Nature. The results indicate that Bedaquiline and Linezolid exhibit pharmacokinetic variability and the occurrence of side effects. Therefore, TDM is recommended for Bedaquiline and Linezolid to achieve desired therapeutic effects and avoid the onset of side effects or toxicity